A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Exenatide (Primary) ; Metformin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Amylin Pharmaceuticals; AstraZeneca
- 10 Jun 2017 Biomarkers information updated
- 29 Feb 2012 Results published in Diabetic Medicine.
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History